Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study.
Hadjadj J, Canzian A, Karadag O, Contis A, Maurier F, Sanges S, Sartorelli S, Denis L, de Moreuil C, Durel CA, Durupt S, Jachiet M, Rouzaud D, Salvarani C, Padoan R, Dagna L, Bonnet F, Agard C, Moulinet T, Hermet M, Sterpu R, Maria ATJ, Keraen J, Guillevin L, Jayne D, Terrier B. Hadjadj J, et al. Among authors: durupt s. Rheumatology (Oxford). 2022 Dec 23;62(1):341-346. doi: 10.1093/rheumatology/keac332. Rheumatology (Oxford). 2022. PMID: 35686919
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.
Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B; French Vasculitis Study Group. Danlos FX, et al. Among authors: durupt s. Autoimmun Rev. 2017 Oct;16(10):1036-1043. doi: 10.1016/j.autrev.2017.07.020. Epub 2017 Aug 2. Autoimmun Rev. 2017. PMID: 28780079 Review.
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.
Durel CA, Hot A, Trefond L, Aumaitre O, Pugnet G, Samson M, Abad S, Belot A, Blanchard-Delaunay C, Cohen P, Cohen-Aubard F, Cottin V, Crestani B, Moreuil C, Durupt S, Garzaro M, Girszyn N, Godeau B, Hachulla E, Jamilloux Y, Jego P, Killian M, Lazaro E, Le Gallou T, Liozon E, Martin T, Papo T, Perlat A, Pillet P, Guillevin L, Terrier B. Durel CA, et al. Among authors: durupt s. Rheumatology (Oxford). 2019 Sep 1;58(9):1565-1573. doi: 10.1093/rheumatology/kez071. Rheumatology (Oxford). 2019. PMID: 30887055
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Thietart S, Karras A, Augusto JF, Philipponnet C, Carron PL, Delbrel X, Mesbah R, Blaison G, Duffau P, El Karoui K, Smets P, London J, Mouthon L, Guillevin L, Terrier B, Puéchal X; French Vasculitis Study Group. Thietart S, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2220925. doi: 10.1001/jamanetworkopen.2022.20925. JAMA Netw Open. 2022. PMID: 35802372 Free PMC article.
Bone marrow involvement in systemic lupus erythematosus.
Chalayer E, Costedoat-Chalumeau N, Beyne-Rauzy O, Ninet J, Durupt S, Tebib J, Asli B, Lambotte O, Ffrench M, Vasselon C, Cathébras P. Chalayer E, et al. Among authors: durupt s. QJM. 2017 Nov 1;110(11):701-711. doi: 10.1093/qjmed/hcx102. QJM. 2017. PMID: 28525589
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders.
Rossignol J, Ouedrani A, Livideanu CB, Barete S, Terriou L, Launay D, Lemal R, Greco C, Frenzel L, Meni C, Bodemere-Skandalis C, Polivka L, Collange AF, Hachichi H, Bouzourine S, Messaoud DN, Negretto M, Vendrame L, Jambou M, Gousseff M, Durupt S, Lega JC, Durand JM, Gaudy C, Damaj G, Gourin MP, Hamidou M, Bouillet L, Le Mouel E, Maria A, Zunic P, Cabrera Q, Vincent D, Lavigne C, Riviere E, Gourguechon C, Courbebaisse M, Lebeaux D, Parfait B, Friedlander G, Brignier A, Lhermitte L, Molina TJ, Bruneau J, Agopian J, Dubreuil P, Ranta D, Mania A, Arock M, Staropoli I, Tournilhac O, Lortholary O, Schwartz O, Chatenoud L, Hermine O. Rossignol J, et al. Among authors: durupt s. J Allergy Clin Immunol Pract. 2022 May;10(5):1356-1364.e2. doi: 10.1016/j.jaip.2021.12.038. Epub 2022 Jan 21. J Allergy Clin Immunol Pract. 2022. PMID: 35074600 Free PMC article.
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
79 results